Activation of hypoxia-inducible factors prevents diabetic nephropathy.
about
Recent advances in understanding of chronic kidney diseaseMechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Cobalt Chloride Upregulates Impaired HIF-1α Expression to Restore Sevoflurane Post-conditioning-Dependent Myocardial Protection in Diabetic Rats.Renal Oxygenation in the Pathophysiology of Chronic Kidney Disease.Inflammation and hypoxia in the kidney: friends or foes?HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron.Renal Hypoxia in CKD; Pathophysiology and Detecting Methods.Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice.Tubular atrophy in the pathogenesis of chronic kidney disease progression.Glucose Homeostasis and Cardiovascular Alterations in Diabetes.Adaptive response to hypoxia and remote ischaemia pre-conditioning: a new hypoxia-inducible factors era in clinical medicine.Renal injury is accelerated by global hypoxia-inducible factor 1 alpha deficiency in a mouse model of STZ-induced diabetes.HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy.Expanding roles of the hypoxia-response network in chronic kidney disease.Quantitating intracellular oxygen tension in vivo by phosphorescence lifetime measurement.A mechanistic link between renal ischemia and fibrosis.The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.Mitochondrial Reactive Oxygen Species and Kidney Hypoxia in the Development of Diabetic NephropathySelective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis.Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.Cooperative Oxygen Sensing by the Kidney and Carotid Body in Blood Pressure Control.A breath of fresh air for diabetic nephropathy.Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1α levels in type-1 diabetic rats.Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db mice.Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy.Renal hypoxia in kidney disease: Cause or consequence?Glucosuria and all-cause mortality among general screening participants.Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery.Adenosine A2 a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress.Deficiency of hypoxia inducible factor-1α promoted progression of diabetic nephropathy with hypertension
P2860
Q26827631-3F2C68D0-B9BD-4738-8569-D0644E8AA644Q33633674-3412E4CB-F0CD-40D0-91B1-E3AB7C627194Q33790008-D759954A-9849-4F33-88DE-94D083E9CEA5Q33843362-2C64CADE-9CD4-4745-BB0A-E3C32FD1662AQ35947605-68715B2A-9482-41C5-8E65-AE0B494D11A8Q36820740-C5F80701-B800-4D3B-9E86-073C5935B758Q37072443-3B67DBA2-3071-4CD2-995C-4945604CBC08Q37653803-18431244-DE51-4F4A-A2EE-68CF992AEC4DQ38293028-5FC3361F-65DF-4585-87F1-D2A96FECB8CDQ38553671-9E82FCC0-C087-4BB6-9C3D-2D6A5B9B196AQ38596700-6E462EE4-EA27-45D4-BF23-66842EF1BF83Q38602621-5195481B-09CF-4FB9-8550-C97445358CEAQ38642880-97C3546A-2E34-4BE4-8457-9B7B287F8AC7Q38666170-97F14E3E-47B8-4284-86B7-6872CD21AC13Q38716178-5F4BEF83-B9F9-454F-85D1-DFC1A7689978Q38726764-D611A8B5-A498-44BA-ADF1-28A60DCC3264Q38813839-0A7F5637-B2FA-479B-BCB8-36B5DDB1B5AAQ38903388-9C13E8C0-6032-4782-912E-A80ADF7D40D6Q39173994-FEF3B857-64C9-4296-80B4-C340EAA93FBDQ39262741-208DA782-0240-403D-91FA-71A6190DF4E6Q41193367-4B204322-8DD6-4CAB-82C0-31991A49C670Q41652349-3317E970-B780-4359-B84D-21BF00AB855BQ41849322-BD62EBBE-5EEE-40CC-A98B-FC048EC89453Q42372768-A91C0B2E-F24F-47CA-86C6-CCC56B1D8C6CQ43123393-1C2A1165-B13A-473F-B0FC-584287D64E31Q47142045-7ECF2124-D1A1-40B2-87D3-160AC289F5FDQ47677176-EB1C55C3-B46F-4785-A87C-32B0616098E0Q47757479-8EF7EB8E-3B20-4737-B9E7-DCEDEDA82EC6Q49842384-90F46700-5818-4E19-990C-CFF2E308B6ADQ50057769-E3F1DFD9-A2A4-4B34-A460-B4D8AD13DDC9Q52931174-7F9AE8DA-9BBE-4DA5-A3EF-427A8E832719Q52950232-3141524A-086F-4FF8-B949-8229746B3051Q58733289-03F0CA27-CEF1-4EE0-87FE-B3560608981F
P2860
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@ast
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@en
type
label
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@ast
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@en
prefLabel
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@ast
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@en
P2093
P2860
P356
P1476
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
@en
P2093
Angelica Fasching
Fredrik Palm
Kumi Shoji
Malou Friederich-Persson
Masaomi Nangaku
P2860
P304
P356
10.1681/ASN.2013090990
P577
2014-09-02T00:00:00Z